Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.110
-0.020 (-0.64%)
Jun 26, 2025, 12:39 PM - Market open
Biomerica Revenue
Biomerica had revenue of $1.12M in the quarter ending February 28, 2025, with 10.03% growth. This brings the company's revenue in the last twelve months to $5.68M, up 5.01% year-over-year. In the fiscal year ending May 31, 2024, Biomerica had annual revenue of $5.42M with 1.42% growth.
Revenue (ttm)
$5.68M
Revenue Growth
+5.01%
P/S Ratio
1.25
Revenue / Employee
$88,719
Employees
64
Market Cap
7.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 5.42M | 76.00K | 1.42% |
May 31, 2023 | 5.34M | -13.53M | -71.71% |
May 31, 2022 | 18.87M | 11.67M | 162.13% |
May 31, 2021 | 7.20M | 506.32K | 7.57% |
May 31, 2020 | 6.69M | 1.49M | 28.69% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
BMRA News
- 4 hours ago - Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer - GlobeNewsWire
- 20 days ago - Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair - GlobeNewsWire
- 21 days ago - Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - GlobeNewsWire
- 5 weeks ago - Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System - GlobeNewsWire
- 7 weeks ago - PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - GlobeNewsWire
- 2 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - GlobeNewsWire
- 2 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - GlobeNewsWire
- 2 months ago - Biomerica Announces Reverse Stock Split - GlobeNewsWire